(ORES) Investment Oresund - Ratings and Ratios
Securities, Properties, Nordic
ORES EPS (Earnings per Share)
ORES Revenue
Description: ORES Investment Oresund
Investment AB Öresund is a Swedish investment company that engages in asset management activities, primarily investing in Nordic securities. With a history dating back to 1890, the company has established itself as a significant player in the Swedish financial landscape.
The companys investment strategy focuses on Nordic securities, indicating a regional expertise that allows it to capitalize on market opportunities within this geographic area. As a Multi-Sector Holdings company, Investment AB Öresund diversifies its investments across various sectors, potentially mitigating risk and enhancing returns.
To evaluate the companys performance, key performance indicators (KPIs) such as Return on Equity (RoE) of 14.04% indicate a relatively strong ability to generate profits from shareholders equity. The Market Capitalization of 5980.53M SEK signifies a substantial market presence. The Price-to-Earnings (P/E) ratio of 8.85 suggests that the stock may be undervalued relative to its earnings, potentially making it an attractive investment opportunity.
Further analysis of the companys financial health and investment portfolio would be necessary to determine its overall attractiveness as an investment. Key metrics such as dividend yield, debt-to-equity ratio, and the composition of its investment portfolio could provide additional insights into its financial stability and growth potential.
Given its long history and established presence in Sweden, Investment AB Öresund appears to be a stable investment option with a proven track record. Investors should, however, consider their individual financial goals and risk tolerance before making investment decisions.
ORES Stock Overview
| Market Cap in USD | 560m |
| Sub-Industry | Multi-Sector Holdings |
| IPO / Inception |
ORES Stock Ratings
| Growth Rating | 27.7% |
| Fundamental | 63.6% |
| Dividend Rating | 67.3% |
| Return 12m vs S&P 500 | -11.0% |
| Analyst Rating | - |
ORES Dividends
| Dividend Yield 12m | 6.07% |
| Yield on Cost 5y | 7.55% |
| Annual Growth 5y | 3.13% |
| Payout Consistency | 75.9% |
| Payout Ratio | 45.9% |
ORES Growth Ratios
| Growth Correlation 3m | 49.6% |
| Growth Correlation 12m | 54.1% |
| Growth Correlation 5y | 13.5% |
| CAGR 5y | 4.96% |
| CAGR/Max DD 5y | 0.12 |
| Sharpe Ratio 12m | -1.89 |
| Alpha | -4.71 |
| Beta | 0.456 |
| Volatility | 19.58% |
| Current Volume | 44.6k |
| Average Volume 20d | 35.8k |
| Stop Loss | 116.2 (-3%) |
| Signal | -0.97 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (689.5m TTM) > 0 and > 6% of Revenue (6% = 47.7m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -0.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.41% (prev 3.69%; Δ -8.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 171.0m <= Net Income 689.5m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.82 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (45.5m) change vs 12m ago 2.30% (target <= -2.0% for YES) |
| Gross Margin 98.19% (prev 92.82%; Δ 5.37pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 15.27% (prev 8.17%; Δ 7.10pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -3.74 (EBITDA TTM -53.8m / Interest Expense TTM 14.4m) >= 6 (WARN >= 3) |
Altman Z'' 23.27
| (A) -0.01 = (Total Current Assets 159.4m - Total Current Liabilities 194.4m) / Total Assets 5.39b |
| (B) 0.71 = Retained Earnings (Balance) 3.81b / Total Assets 5.39b |
| (C) -0.01 = EBIT TTM -53.8m / Avg Total Assets 5.20b |
| (D) 20.08 = Book Value of Equity 4.15b / Total Liabilities 206.8m |
| Total Rating: 23.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.61
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield 3.29% = 1.65 |
| 3. FCF Margin 21.53% = 5.38 |
| 4. Debt/Equity 0.00 = 2.50 |
| 5. Debt/Ebitda -0.23 = -2.50 |
| 6. ROIC - WACC -1.07% = -1.34 |
| 7. RoE 14.04% = 1.17 |
| 8. Rev. Trend 55.70% = 2.78 |
| 9. Rev. CAGR 364.7% = 2.50 |
| 10. EPS Trend 38.56% = 0.96 |
| 11. EPS CAGR 254.8% = 2.50 |
What is the price of ORES shares?
Over the past week, the price has changed by -1.16%, over one month by -7.85%, over three months by +3.81% and over the past year by +4.11%.
Is Investment Oresund a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ORES is around 116.63 SEK . This means that ORES is currently overvalued and has a potential downside of -2.65%.
Is ORES a buy, sell or hold?
What are the forecasts/targets for the ORES price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 138 | 15.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 129.1 | 7.8% |
ORES Fundamental Data Overview
Market Cap SEK = 5.33b (5.33b SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 148.2m SEK (last quarter)
P/E Trailing = 7.884
P/S = 7.2744
P/B = 1.0382
Beta = 0.82
Revenue TTM = 794.3m SEK
EBIT TTM = -53.8m SEK
EBITDA TTM = -53.8m SEK
Long Term Debt = 12.4m SEK (from longTermDebtTotal, last quarter)
Short Term Debt = unknown (0.0)
Debt = 12.4m SEK (Calculated: Short Term 0.0 + Long Term 12.4m)
Net Debt = -135.8m SEK (from netDebt column, last quarter)
Enterprise Value = 5.19b SEK (5.33b + Debt 12.4m - CCE 148.2m)
Interest Coverage Ratio = -3.74 (Ebit TTM -53.8m / Interest Expense TTM 14.4m)
FCF Yield = 3.29% (FCF TTM 171.0m / Enterprise Value 5.19b)
FCF Margin = 21.53% (FCF TTM 171.0m / Revenue TTM 794.3m)
Net Margin = 86.81% (Net Income TTM 689.5m / Revenue TTM 794.3m)
Gross Margin = 98.19% ((Revenue TTM 794.3m - Cost of Revenue TTM 14.4m) / Revenue TTM)
Tobins Q-Ratio = 1.25 (Enterprise Value 5.19b / Book Value Of Equity 4.15b)
Interest Expense / Debt = 116.1% (Interest Expense 14.4m / Debt 12.4m)
Taxrate = 0.0% (from yearly Tax Provision: 0.0 / 246.6m)
NOPAT = -53.8m (EBIT -53.8m, no tax applied on loss)
Current Ratio = 0.82 (Total Current Assets 159.4m / Total Current Liabilities 194.4m)
Debt / Equity = 0.00 (Debt 12.4m / last Quarter total Stockholder Equity 5.19b)
Debt / EBITDA = -0.23 (Net Debt -135.8m / EBITDA -53.8m)
Debt / FCF = 0.07 (Debt 12.4m / FCF TTM 171.0m)
Total Stockholder Equity = 4.91b (last 4 quarters mean)
RoA = 12.79% (Net Income 689.5m, Total Assets 5.39b )
RoE = 14.04% (Net Income TTM 689.5m / Total Stockholder Equity 4.91b)
RoCE = -1.09% (Ebit -53.8m / (Equity 4.91b + L.T.Debt 12.4m))
RoIC = -1.07% (NOPAT -53.8m / Invested Capital 5.04b)
WACC = unknown (E(5.33b)/V(5.34b) * Re(7.70%)) + (D(12.4m)/V(5.34b) * Rd(none%) * (1-Tc(0.0)))
Shares Correlation 5-Years: 22.40 | Cagr: 0.0%
Discount Rate = 7.70% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.22% ; FCFE base≈167.9m ; Y1≈204.0m ; Y5≈336.3m
Fair Price DCF = 128.7 (DCF Value 5.73b / Shares Outstanding 44.6m; 5y FCF grow 23.00% → 3.0% )
Revenue Correlation: 55.70 | Revenue CAGR: 364.7%
Rev Growth-of-Growth: 74.73
EPS Correlation: 38.56 | EPS CAGR: 254.8%
EPS Growth-of-Growth: -10.44